Concepedia

Rajeeva Singh

RS

Statistics

Publications

39

Citations

3.1K

H-Index

27

Active since

1978

Affiliations

ImmunoGen (United States)(Current)

The University of Texas at Austin

AbbVie (United States)

Rajeeva Singh is an author at ImmunoGen (United States) specializing in biochemistry, antibody-drug conjugates, and pharmacy.

ORCID

Publications per year

1978–2024

39

Publications

39

An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.

Erin K. Maloney, Jennifer L McLaughlin, Nancy E Dagdigian et al. · PubMed · 2003 · 309 citations

, , +13

Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance

Yelena Kovtun, Charlene A. Audette, Michele Mayo et al. · Cancer Research · 2010 · 259 citations

, , +16

Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates

Hans K. Erickson, Wayne C. Widdison, Michele Mayo et al. · Bioconjugate Chemistry · 2009 · 240 citations

, , +17

IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors

Olga Ab, Kathleen R. Whiteman, Laura M. Bartle et al. · Molecular Cancer Therapeutics · 2015 · 224 citations

, , +17

Disulfide-Linked Antibody−Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage

Brenda Kellogg, Lisa M. Garrett, Yelena Kovtun et al. · Bioconjugate Chemistry · 2011 · 210 citations

, , +17

1–5 of 39